The lack of a biomarker-specific time course for PCT in this cohort as well as the smaller sample size does not allow a direct head-to-head comparison to the other markers and may also weaken its prognostic strength for infections, which should be analyzed in further prospective studies. This evidence concerns the gene CALCA and infection.